Neutralizing Efficacy of Encapsulin Nanoparticles against SARS-CoV2 Variants of Concern

Rapid emergence of the SARS-CoV-2 variants has dampened the protective efficacy of existing authorized vaccines. Nanoparticle platforms offer a means to improve vaccine immunogenicity by presenting multiple copies of desired antigens in a repetitive manner which closely mimics natural infection. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Khaleeq, Sara, Sengupta, Nayanika, Kumar, Sahil, Patel, Unnatiben Rajeshbhai, Rajmani, Raju S., Reddy, Poorvi, Pandey, Suman, Singh, Randhir, Dutta, Somnath, Ringe, Rajesh P., Varadarajan, Raghavan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961482/
https://www.ncbi.nlm.nih.gov/pubmed/36851560
http://dx.doi.org/10.3390/v15020346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961482/
https://www.ncbi.nlm.nih.gov/pubmed/36851560
http://dx.doi.org/10.3390/v15020346

Ejemplares similares